Skip to main content

Invasive Pulmonary Aspergillosis in Solid Organ Transplant Recipients

  • Chapter
  • First Online:
Aspergillosis: From Diagnosis to Prevention

Abstract

Invasive aspergillosis (IA) continues to be a significant cause of morbidity and mortality in solid organ transplant recipients. The highest incidence of IA is noted in lung transplant recipients, while the lowest incidence is in kidney transplant recipients. Common risk factors for the development of invasive aspergillosis include environmental exposures and net state of immunosuppression. Unique risk factors to lung transplants include airway colonization, and receipt of single lung transplant. Liver transplant recipients receiving renal replacement therapy on the other hand have the highest risk of IA. Liver transplant recipients also have the highest incidence of disseminated disease while tracheobronchitis is the most common manifestation of IA in lung transplant recipients. Prophylaxis with antifungal agents is recommended in lung and liver transplant recipients. The drug of choice for the treatment of IA remains to be voriconazole. The role of combination therapy for the treatment of IA in solid organ transplant recipients remains undetermined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Silveira, F. P. & Husain, S. (2007) Fungal infections in solid organ transplantation. Med Mycol, 45, 305–20.

    Article  PubMed  Google Scholar 

  2. Singh, N. & Paterson, D. L. (2005) Aspergillus infections in transplant recipients. Clin Microbiol Rev, 18, 44–69.

    Article  CAS  PubMed  Google Scholar 

  3. Cahill, B. C., Hibbs, J. R., Savik, K., Juni, B. A., Dosland, B. M., Edin-Stibbe, C. & Hertz, M. I. (1997) Aspergillus airway colonization and invasive disease after lung transplantation. Chest, 112, 1160–64.

    Article  CAS  PubMed  Google Scholar 

  4. Husain, S., Kwak, E. J., Obman, A., Wagener, M. M., Kusne, S., Stout, J. E., Mccurry, K. R. & Singh, N. (2004) Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients. Am J Transplant, 4, 796–802.

    Article  PubMed  Google Scholar 

  5. Husni, R. N., Gordon, S. M., Longworth, D. L., Arroliga, A., Stillwell, P. C., Avery, R. K., Maurer, J. R., Mehta, A. & Kirby, T. (1998) Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis, 26, 753–55.

    Article  CAS  PubMed  Google Scholar 

  6. Mehrad, B., Paciocco, G., Martinez, F. J., Ojo, T. C., Iannettoni, M. D. & Lynch, J. P., 3RD (2001) Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest, 119, 169–75.

    Article  CAS  PubMed  Google Scholar 

  7. Minari, A., Husni, R., Avery, R. K., Longworth, D. L., Decamp, M., Bertin, M., Schilz, R., Smedira, N., Haug, M. T., Mehta, A. & Gordon, S. M. (2002) The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis, 4, 195–200.

    Article  CAS  PubMed  Google Scholar 

  8. Westney, G. E., Kesten, S., De Hoyos, A., Chapparro, C., Winton, T. & Maurer, J. R. (1996) Aspergillus infection in single and double lung transplant recipients. Transplantation, 61, 915–19.

    Article  CAS  PubMed  Google Scholar 

  9. Singh, N. & Husain, S. (2003) Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant, 22, 258–66.

    Article  PubMed  Google Scholar 

  10. Montoya, J. G., Chaparro, S. V., Celis, D., Cortes, J. A., Leung, A. N., Robbins, R. C. & Stevens, D. A. (2003) Invasive aspergillosis in the setting of cardiac transplantation. Clin Infect Dis, 37 Suppl 3, S281–92.

    Article  PubMed  Google Scholar 

  11. Munoz, P., Rodriguez, C., Bouza, E., Palomo, J., Yanez, J. F., Dominguez, M. J. & Desco, M. (2004) Risk factors of invasive aspergillosis after heart transplantation: protective role of oral itraconazole prophylaxis. Am J Transplant, 4, 636–43.

    Article  CAS  PubMed  Google Scholar 

  12. Singh, N. (2000) Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. Clin Infect Dis, 31, 545–53.

    Article  CAS  PubMed  Google Scholar 

  13. Cornet, M., Fleury, L., Maslo, C., Bernard, J. F. & Brucker, G. (2002) Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area. J Hosp Infect, 51, 288–96.

    Article  CAS  PubMed  Google Scholar 

  14. Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G. & Warnock, D. W. (2005) Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol, 43 Suppl 1, S49–58.

    Article  PubMed  Google Scholar 

  15. George, M. J., Snydman, D. R., Werner, B. G., Griffith, J., Falagas, M. E., Dougherty, N. N. & Rubin, R. H. (1997) The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. Am J Med, 103, 106–13.

    Article  CAS  PubMed  Google Scholar 

  16. Snydman, D. R., Falagas, M. E., Avery, R., Perlino, C., Ruthazer, R., Freeman, R., Rohrer, R., Fairchild, R., O’rourke, E., Hibberd, P. & Werner, B. G. (2001) Use of combination cytomegalovirus immune globulin plus ganciclovir for prophylaxis in CMV-seronegative liver transplant recipients of a CMV-seropositive donor organ: a multicenter, open-label study. Transplant Proc, 33, 2571–75.

    Article  CAS  PubMed  Google Scholar 

  17. Snydman, D. R., Werner, B. G., Heinze-Lacey, B., Berardi, V. P., Tilney, N. L., Kirkman, R. L., Milford, E. L., Cho, S. I., Bush, H. L., JR., Levey, A. S. et al. (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med, 317, 1049–54.

    Article  CAS  PubMed  Google Scholar 

  18. Rubin, R. H. (1989) The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA, 261, 3607–09.

    Article  CAS  PubMed  Google Scholar 

  19. Chan, K. M. & Allen, S. A. (2002) Infectious pulmonary complications in lung transplant recipients. Semin Respir Infect, 17, 291–302.

    Article  PubMed  Google Scholar 

  20. Higgins, R., Mcneil, K., Dennis, C., Parry, A., Large, S., Nashef, S. A., Wells, F. C., Flower, C. & Wallwork, J. (1994) Airway stenoses after lung transplantation: management with expanding metal stents. J Heart Lung Transplant, 13, 774–78.

    CAS  PubMed  Google Scholar 

  21. Goldfarb, N. S., Avery, R. K., Goormastic, M., Mehta, A. C., Schilz, R., Smedira, N., Pien, L., Haug, M. T., Gordon, S. M., Hague, L. K., Dresing, J. M., Evans-Walker, T. & Maurer, J. R. (2001) Hypogammaglobulinemia in lung transplant recipients. Transplantation, 71, 242–46.

    Article  CAS  PubMed  Google Scholar 

  22. Crespo, M. M., Raza, K., Johnson, B. A., Mccurry, K. R., Pilewski, J. & Husain, S. (2006) Risk of pulmonary aspergillosis after bronchial stent placement in lung transplant (LTX) recipients. in 26th Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation.. Madrid, Spain.

    Google Scholar 

  23. Kubak, B. M. (2002) Fungal infection in lung transplantation. Transpl Infect Dis, 4 Suppl 3, 24–31.

    Article  PubMed  Google Scholar 

  24. Gordon, S. M. & Avery, R. K. (2001) Aspergillosis in lung transplantation: incidence, risk factors, and prophylactic strategies. Transpl Infect Dis, 3, 161–67.

    Article  CAS  PubMed  Google Scholar 

  25. Paradis, I. L. & Williams, P. (1993) Infection after lung transplantation. Semin Respir Infect, 8, 207–15.

    CAS  PubMed  Google Scholar 

  26. Nunley, D. R., Ohori, P., Grgurich, W. F., Iacono, A. T., Williams, P. A., Keenan, R. J. & Dauber, J. H. (1998) Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest, 114, 1321–29.

    Article  CAS  PubMed  Google Scholar 

  27. Husain, S., Raza, K., Paterson, D. L., Pilewski, J., Spichty, K., Zaldonis, D., Carey, M. E., Kowlaski, R., Post, D., Britz, J., Mccurry, K. R. & Zeevi, A. (2007) Impact of various infectious syndromes on the immune function profile in lung transplant recipients. Am J Transplant, 7, 245–6.

    Google Scholar 

  28. Fortun, J., Martin-Davila, P., Moreno, S., De Vicente, E., Nuno, J., Candelas, A., Barcena, R. & Garcia, M. (2002) Risk factors for invasive aspergillosis in Liver Transplant recipients. Liver Transpl, 8, 1065–70.

    Article  PubMed  Google Scholar 

  29. Singh, N., Pruett, T. L., Houston, S., Munoz, P., Cacciarelli, T. V., Wagener, M. M. & Husain, S. (2006) Invasive aspergillosis in the recipients of liver retransplantation. Liver Transpl, 12, 1205–9.

    Article  PubMed  Google Scholar 

  30. Gayowski, T., Marino, I. R., Singh, N., Doyle, H., Wagener, M., Fung, J. J. & Starzl, T. E. (1998) Orthotopic liver Transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation, 65, 499–504.

    Article  CAS  PubMed  Google Scholar 

  31. Paterson, D. L., Singh, N., Gayowski, T. & Marino, I. R. (1998) Pulmonary nodules in liver transplant recipients. Medicine (Baltimore), 77, 50–8.

    Article  CAS  Google Scholar 

  32. Paterson, D. L. & Singh, N. (1999) Invasive aspergillosis in transplant recipients. Medicine (Baltimore), 78, 123–38.

    Article  CAS  Google Scholar 

  33. Helmi, M., Love, R. B., Welter, D., Cornwell, R. D. & Meyer, K. C. (2003) Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest, 123, 800–88.

    Article  PubMed  Google Scholar 

  34. Husain, S., Paterson, D. L., Studer, S., Pilewski, J., Crespo, M., Zaldonis, D., Shutt, K., Pakstis, D. L., Zeevi, A., Johnson, B., Kwak, E. J. & Mccurry, K. R. (2006) Voriconazole prophylaxis in lung transplant recipients. Am J Transplant, 6, 3008–16.

    Article  CAS  PubMed  Google Scholar 

  35. Kramer, M. R., Denning, D. W., Marshall, S. E., Ross, D. J., Berry, G., Lewiston, N. J., Stevens, D. A. & Theodore, J. (1991) Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis, 144, 552–56.

    CAS  PubMed  Google Scholar 

  36. Singh, N., Arnow, P. M., Bonham, A., Dominguez, E., Paterson, D. L., Pankey, G. A., Wagener, M. M. & Yu, V. L. (1997) Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation, 64, 716–20.

    Article  CAS  PubMed  Google Scholar 

  37. Singh, N., Avery, R. K., Munoz, P., Pruett, T. L., Alexander, B., Jacobs, R., Tollemar, J. G., Dominguez, E. A., Yu, C. M., Paterson, D. L., Husain, S., Kusne, S. & Linden, P. (2003) Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients. Clin Infect Dis, 36, 46–52.

    Article  PubMed  Google Scholar 

  38. Rasmussen, C., Garen, C., Brining, S., Kincaid, R. L., Means, R. L. & Means, A. R. (1994) The calmodulin-dependent protein phosphatase catalytic subunit (calcineurin A) is an essential gene in Aspergillus nidulans. EMBO J, 13, 2545–52.

    CAS  PubMed  Google Scholar 

  39. Singh, N. & Heitman, J. (2004) Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients. Transplantation, 77, 795–800.

    Article  CAS  PubMed  Google Scholar 

  40. Kontoyiannis, D. P., Lewis, R. E., Osherov, N., Albert, N. D. & May, G. S. (2003) Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J Antimicrob Chemother, 51, 313–16.

    Article  CAS  PubMed  Google Scholar 

  41. Munoz, P., Alcala, L., Sanchez Conde, M., Palomo, J., Yanez, J., Pelaez, T. & Bouza, E. (2003) The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation, 75, 326–29.

    Article  PubMed  Google Scholar 

  42. Grossi, P., Farina, C., Fiocchi, R. & Dalla Gasperina, D. (2000) Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation, 70, 112–16.

    CAS  PubMed  Google Scholar 

  43. Kusne, S., Torre-Cisneros, J., Manez, R., Irish, W., Martin, M., Fung, J., Simmons, R. L. & Starzl, T. E. (1992) Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J Infect Dis, 166, 1379–83.

    CAS  PubMed  Google Scholar 

  44. Perfect, J. R., Cox, G. M., Lee, J. Y., Kauffman, C. A., De Repentigny, L., Chapman, S. W., Morrison, V. A., Pappas, P., Hiemenz, J. W. & Stevens, D. A. (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis, 33, 1824–33.

    Article  CAS  PubMed  Google Scholar 

  45. Weiland, D., Ferguson, R. M., Peterson, P. K., Snover, D. C., Simmons, R. L. & Najarian, J. S. (1983) Aspergillosis in 25 renal transplant patients. Epidemiology, clinical presentation, diagnosis, and management. Ann Surg, 198, 622–29.

    Article  CAS  PubMed  Google Scholar 

  46. Brown, R. S., JR., Lake, J. R., Katzman, B. A., Ascher, N. L., Somberg, K. A., Emond, J. C. & Roberts, J. P. (1996) Incidence and significance of Aspergillus cultures following liver and kidney Transplantation. Transplantation, 61, 666–69.

    Article  PubMed  Google Scholar 

  47. Fortun, J., Martin-Davila, P., Alvarez, M. E., Sanchez-Sousa, A., Quereda, C., Navas, E., Barcena, R., Vicente, E., Candelas, A., Honrubia, A., Nuno, J., Pintado, V. & Moreno, S. (2001) Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation, 71, 145–49.

    Article  CAS  PubMed  Google Scholar 

  48. Kwak, E. J., Husain, S., Obman, A., Meinke, L., Stout, J., Kusne, S., Wagener, M. M. & Singh, N. (2004) Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients. J Clin Microbiol, 42, 435–38.

    Article  PubMed  Google Scholar 

  49. Pfeiffer, C. D., Fine, J. P. & Safdar, N. (2006) Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis, 42, 1417–27.

    Article  CAS  PubMed  Google Scholar 

  50. Husain, S., Paterson, D. L., Studer, S. M., Crespo, M., Pilewski, J., Durkin, M., Wheat, J. L., Johnson, B., Mclaughlin, L., Bentsen, C., Mccurry, K. R. & Singh, N. (2007) Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation, 83, 1330–36.

    Article  CAS  PubMed  Google Scholar 

  51. Clancy, C. J., Jaber, R. A., Leather, H. L., Wingard, J. R., Staley, B., Wheat, L. J., Cline, C. L., Rand, K. H., Schain, D., Baz, M. & Nguyen, M. H. (2007) Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol, 45, 1759–65.

    Article  CAS  PubMed  Google Scholar 

  52. Pasqualotto, A. C. & Sukiennik, T. C. (2008) Beta-glucan in the diagnosis of invasive fungal disease. Clin Infect Dis, 47, 292–3; author reply 3–4.

    Article  PubMed  Google Scholar 

  53. Yoshida, M., Obayashi, T., Iwama, A., Ito, M., Tsunoda, S., Suzuki, T., Muroi, K., Ohta, M., Sakamoto, S. & Miura, Y. (1997) Detection of plasma (1 –> 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol, 35, 371–4.

    Article  CAS  PubMed  Google Scholar 

  54. Ascioglu, S., Rex, J. H., De Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., Fiere, D., Lortholary, O., Maertens, J., Meis, J. F., Patterson, T. F., Ritter, J., Selleslag, D., Shah, P. M., Stevens, D. A. & Walsh, T. J. (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis, 34, 7–14.

    Article  CAS  PubMed  Google Scholar 

  55. Akamatsu, N., Sugawara, Y., Kaneko, J., Tamura, S. & Makuuchi, M. (2007) Preemptive treatment of fungal Infection based on plasma (1 –> 3)beta-D-glucan levels after liver transplantation. Infection, 35, 346–51.

    Article  CAS  PubMed  Google Scholar 

  56. Singh, N. (2003) Treatment of opportunistic mycoses: how long is long enough? Lancet Infect Dis, 3, 703–8.

    Article  PubMed  Google Scholar 

  57. Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J. W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., Sylvester, R., Rubin, R. H., Wingard, J. R., Stark, P., Durand, C., Caillot, D., Thiel, E., Chandrasekar, P. H., Hodges, M. R., Schlamm, H. T., Troke, P. F. & De Pauw, B. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med, 347, 408–15.

    Article  CAS  PubMed  Google Scholar 

  58. Marty, F. M., Lowry, C. M., Cutler, C. S., Campbell, B. J., Fiumara, K., Baden, L. R. & Antin, J. H. (2006) Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, 12, 552–59.

    Article  CAS  PubMed  Google Scholar 

  59. Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J. & Marchetti, O. (2008) Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis, 46, 201–11.

    Article  CAS  PubMed  Google Scholar 

  60. Smith, J., Safdar, N., Knasinski, V., Simmons, W., Bhavnani, S. M., Ambrose, P. G. & Andes, D. (2006) Voriconazole therapeutic drug monitoring. Antimicrob Agents Chemother, 50, 1570–72.

    Article  CAS  PubMed  Google Scholar 

  61. Tan, K., Brayshaw, N., Tomaszewski, K., Troke, P. & Wood, N. (2006) Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities. J Clin Pharmacol, 46, 235–43.

    Article  CAS  PubMed  Google Scholar 

  62. Monforte, V., Roman, A., Gavalda, J., Bravo, C., Tenorio, L., Ferrer, A., Maestre, J. & Morell, F. (2001) Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant, 20, 1274–81.

    Article  CAS  PubMed  Google Scholar 

  63. Corcoran, T. E., Venkataramanan, R., Mihelc, K. M., Marcinkowski, A. L., Ou, J., Mccook, B. M., Weber, L., Carey, M. E., Paterson, D. L., Pilewski, J. M., Mccurry, K. R. & Husain, S. (2006) Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant, 6, 2765–73.

    Article  CAS  PubMed  Google Scholar 

  64. Drew, R. H., Dodds Ashley, E., Benjamin, D. K., JR., Duane Davis, R., Palmer, S. M. & Perfect, J. R. (2004) Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation, 77, 232–37.

    Article  CAS  PubMed  Google Scholar 

  65. Lowry, C. M., Marty, F. M., Vargas, S. O., Lee, J. T., Fiumara, K., Deykin, A. & Baden, L. R. (2007) Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study. Transpl Infect Dis, 9, 121–25.

    Article  CAS  PubMed  Google Scholar 

  66. Singh, N., Limaye, A. P., Forrest, G., Safdar, N., Munoz, P., Pursell, K., Houston, S., Rosso, F., Montoya, J. G., Patton, P., Del Busto, R., Aguado, J. M., Fisher, R. A., Klintmalm, G. B., Miller, R., Wagener, M. M., Lewis, R. E., Kontoyiannis, D. P. & Husain, S. (2006) Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation, 81, 320–26.

    Article  CAS  PubMed  Google Scholar 

  67. Singh, N., Wagener, M. M., Cacciarelli, T. V. & Levitsky, J. (2008) Antifungal management practices in liver transplant recipients. Am J Transplant, 8, 426–31.

    Article  CAS  PubMed  Google Scholar 

  68. Dummer, J. S., Lazariashvilli, N., Barnes, J., Ninan, M. & Milstone, A. P. (2004) A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant, 23, 1376–81.

    Article  PubMed  Google Scholar 

  69. Husain, S., Zaldonis, D., Kusne, S., Kwak, E. J., Paterson, D. L. & Mccurry, K. R. (2006) Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis, 8, 213–18.

    Article  CAS  PubMed  Google Scholar 

  70. Tollemar, J., Hockerstedt, K., Ericzon, B. G., Jalanko, H. & Ringden, O. (1995) Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study. Transplantation, 59, 45–50.

    Article  CAS  PubMed  Google Scholar 

  71. Lorf, T., Braun, F., Ruchel, R., Muller, A., Sattler, B. & Ringe, B. (1999) Systemic Mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation. Mycoses, 42, 47–53.

    Article  CAS  PubMed  Google Scholar 

  72. Singh, N., Paterson, D. L., Gayowski, T., Wagener, M. M. & Marino, I. R. (2001) Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring renal replacement therapy. Transplantation, 71, 910–13.

    Article  CAS  PubMed  Google Scholar 

  73. Fortun, J., Martin-Davila, P., Moreno, S., Barcena, R., De Vicente, E., Honrubia, A., Garcia, M., Nuno, J., Candela, A., Uriarte, M. & Pintado, V. (2003) Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother, 52, 813–19.

    Article  CAS  PubMed  Google Scholar 

  74. Calvo, V., Borro, J. M., Morales, P., Morcillo, A., Vicente, R., Tarrazona, V. & Paris, F. (1999) Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group. Chest, 115, 1301–04.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shahid Husain .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Silveira, F.P., Husain, S. (2009). Invasive Pulmonary Aspergillosis in Solid Organ Transplant Recipients. In: Comarú Pasqualotto, A. (eds) Aspergillosis: From Diagnosis to Prevention. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2408-4_34

Download citation

Publish with us

Policies and ethics